SGS Wavre Site Gets WHO Prequalification

SGS Life Science Services‘ site in Wavre, Belgium, has received prequalified status from the World Health Organization (WHO). This status demonstrates that a lab has met established global quality guidelines for Good Practices for National Pharmaceutical Control Laboratories and Good Manufacturing Practices (GMP) and lists the site as eligible to test and release medicines for WHO.

SGS’s site in Chennai India received prequalified status in January 2011. “The members of WHO’s prequalified laboratories is limited to a list of 20 facilities,” said Anne Hays, executive vice president for SGS Life Science Services. “SGS is proud to have the distinction of being the only organization with two prequalified laboratories on the list.”

The site has been in operation since 1971 and is located in the suburbs of Brussels. It has passed inspections by FDA and EMA and operates under GLP, GCP and cGMP.